Results 111 to 120 of about 49,641 (173)

Remdesivir in COVID-19: A Focus on Pediatric Cardiac Patients. [PDF]

Can J Infect Dis Med Microbiol
Bsat D, Safi D, Arabi M.
europepmc   +1 more source

Treatment of non-effusive feline infectious peritonitis using oral remdesivir or GS-441524: a randomized, double-blind, non-inferiority trial. [PDF]

J Feline Med Surg
Brostoff T, Pires J, Rose A, Cohen-Davidyan T, Castillo D, Murphy BG, Reagan KL.   +6 more
europepmc   +1 more source

Remdesivir in COVID-19: pros and cons. [PDF]

Front Pharmacol
Rouhana El Feghali Y, Rabih L, Abdul Khalek J, Arabi M.   +3 more
europepmc   +1 more source

Successful Treatment of Persistent and Relapsing COVID-19 with Ensitrelvir in a Patient with Obinutuzumab-Induced Long-Term B-Cell Depletion: A Case Report. [PDF]

Reports (MDPI)
Haino Y, Kenzaka T, Hayashi T, Yakushijin K.   +3 more
europepmc   +1 more source

Time-varying characteristics of remdesivir-treated patients hospitalised due to COVID-19: an electronic health record study. [PDF]

J Glob Health
Hoe JK, Blond K, Jimenez-Solem E, Berry M, Chiang M, Ankarfeldt MZ, Petersen J.   +6 more
europepmc   +1 more source

Electrocardiographic Profile of Adult Patients with Coronavirus Disease (COVID-19) who were Given Remdesivir and Admitted in the University of the Philippines-Philippine General Hospital (UP-PGH). [PDF]

Acta Med Philipp
Lustestica KEL, Punzalan FER, Alad PAO, Aya-Ay TAP, Nelson ZOM, Ramirez BPG, Santos NJC, Llanes EJB.   +7 more
europepmc   +1 more source

Safety and efficacy of major antiviral and immune therapies in pregnancy for maternal viral infections: evidence synthesis of maternal and neonatal outcomes. [PDF]

Front Med (Lausanne)
Sleman S, Abid OI, Abdullah BJ, Abass ZA, Ameen MB.   +4 more
europepmc   +1 more source

Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe disease. [PDF]

PLoS One
Abdelghany M, Yu F, Rennard S, Gwon Y.
europepmc   +1 more source

Dynamical Fragment Molecular Orbital Interaction Analysis of SARS-CoV‑2 RNA-Dependent RNA Polymerase and Remdesivir. [PDF]

ACS Omega
Miyakawa S, Okuwaki K, Kawashima Y, Handa Y, Furuishi T, Yonemochi E, Kato K, Fukuzawa K.   +7 more
europepmc   +1 more source

Efficacy and safety of remdesivir for patients with severe acute respiratory syndrome coronavirus 2 infection: A systematic review of randomized controlled trials.

Indian J Pharmacol
Meena J, Agarwal A, Sandhu A, Pradhan P, Singh M.   +4 more
europepmc   +1 more source